• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC NAVISTAR; SIMILAR DEVICE NS7TCBL174HS, PMA # P990025

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC NAVISTAR; SIMILAR DEVICE NS7TCBL174HS, PMA # P990025 Back to Search Results
Catalog Number UNK_NAVISTAR
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Pleural Effusion (2010)
Event Date 05/10/2010
Event Type  Injury  
Manufacturer Narrative
No device was received for analysis at the time of submission of the initial 3500a.Since the product was not returned for analysis, no product failure analysis can be conducted and no determination of possible contributing factors could be made.Device history record (dhr) review cannot be conducted because the no lot number was provided by the customer.(b)(4).
 
Event Description
This complaint is from a literature source.It was reported that one patient underwent radiofrequency ablation and developed a hemothorax in group 2.Initially this event is assessed as a non-serious event.Additional information is received on 12/20/2017 indicating that this patient was (b)(6) female and required extended hospitalization.Physician¿s opinion regarding the causality of adverse event is procedure related and patient condition related.The event resulted in the mild impairment of a body function or damage to a body structure.Patient¿s condition is fully recovered (no residual effects).This event is re-assessed as serious injury and mdr reportable with new awareness date 12/20/2017.Title: ¿infarct transmurality as a criterion for first-line endo-epicardial substrate¿guided ventricular tachycardia ablation in ischemic cardiomyopathy¿ the purpose of this study was to investigate whether infarct transmurality (it) could identify patients who would benefit from a combined first-line endo-epicardial approach.Suspect device is a navistar, however catalog and lot number is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NAVISTAR
Type of Device
SIMILAR DEVICE NS7TCBL174HS, PMA # P990025
Manufacturer (Section D)
BIOSENSE WEBSTER INC
33 technology drive
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
joaquin kurz
33 technology drive
irvine, CA 92618
949789-383
MDR Report Key7138383
MDR Text Key95588996
Report Number2029046-2017-01298
Device Sequence Number1
Product Code DRF
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature
Reporter Occupation Health Professional
Type of Report Initial
Report Date 12/20/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK_NAVISTAR
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/17/2017
Initial Date FDA Received12/21/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age63 YR
-
-